Common use of Financial obligations of the Institution Clause in Contracts

Financial obligations of the Institution. The payments specified in Section 5(a) above shall constitute the Institution’s and Investigator’s sole remuneration in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests, if applicable.

Financial obligations of the Institution. The payments specified in Section 5(a) above shall constitute the Institution’s and Investigator’s sole remuneration in connection with for the conduct of the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the pharmacy fees and laboratory tests; however, excluding remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests, if applicable.

Financial obligations of the Institution. The payments specified in Section 5(a4(a) and Schedule A hereof above shall constitute the Institution’s and Investigator’s sole remuneration in connection with for the conduct of the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the remuneration of the Investigator and all Staff members, to pharmacy fees and laboratory tests, if applicable; however excluding remuneration of výplatu odměny Zkoušejícímu. the Investigator.

Financial obligations of the Institution. The payments specified in Section 5(a) above shall constitute the Institution’s, Investigator’s and Investigatorhis/her Team’s sole remuneration in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests, if applicable.

Financial obligations of the Institution. The payments specified in Section 5(a4(a) above shall constitute the Institution’s and Investigator’s sole remuneration in connection with for the conduct of the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the pharmacy fees and laboratory tests; however excluding remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests, if applicable.

Financial obligations of the Institution. The payments specified in Section 5(a) above shall constitute the Institution’s, Investigator’s and Investigatorhis/her Team’s sole remuneration in connection with the Trial. In the event that Biogen has not given its prior express written approval regarding any costs or expenses, the Institution shall be responsible for all costs and expenses arising from the conduct of the Trial, including but not limited to, the remuneration of the Investigator and all Staff members, pharmacy fees and laboratory tests, if applicable.